<DOC>
	<DOCNO>NCT00850317</DOCNO>
	<brief_summary>A research study patient Fanconi Anemia whose bone marrow change fail , give rise pre-leukemia leukemia . This study Phase II clinical trial patient undergo allogenic transplant stem cell , mean receive bone marrow cell healthy donor . The purpose study see transplant course treatment low risk graft vs. host disease .</brief_summary>
	<brief_title>Fanconi Anemia Transplant Lacking Genotypically Identical Donor</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Fanconi Anemia</mesh_term>
	<mesh_term>Fanconi Syndrome</mesh_term>
	<criteria>Diagnosis : Patients must diagnosis Fanconi anemia ( confirm mitomycin C diepoxybutane [ DEB ] chromosomal breakage test approve laboratory ) Hematologic Diagnosis Status : Patients must one follow hematologic diagnosis : 1 . Severe Aplastic Anemia ( SAA ) , Severe Isolated Single lineage Cytopenia bone marrow cellularity &lt; 25 % AND least one follow feature : Platelet count &lt; 20 x 109/L platelet transfusion dependence ANC &lt; 1000 x 109/L Hgb &lt; 8 gm/dl red cell transfusion dependence 2 . Myelodysplatic Syndrome ( MDS ) ( Appendix 1 : MDS Classification ) . MDS stage , base either one follow classification : WHO Classification Refractory anemia transfusion dependence Any stag IPSS Classification Low risk ( score 0 ) transfusion dependence Any risk group Score &gt; 0.5 3 . Acute Myelogenous Leukemia : Patients acute leukemia include trial remission , refractory relapse disease Active CNS leukemic involvement Female patient pregnant breastfeed Active uncontrolled viral , bacterial fungal infection Patient seropositive HIVI/II ; HTLV I/II</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Fanconi Anemia</keyword>
	<keyword>FA</keyword>
	<keyword>Stem Cell Transplant</keyword>
	<keyword>T-Cell</keyword>
</DOC>